SRC (P12931) variants and mutations

SRC (also known as P12931) is a human protein-coding gene encoding a proto-oncogene tyrosine-protein kinase protein. It integrates signals from growth-factor receptors, integrins, and other surface proteins to regulate proliferation, adhesion, migration, and survival. Persistent SRC-family signaling promotes invasion and therapy resistance in many cancers and remains an important therapeutic target. This analysis covers 1,057 SRC variants and mutations. Of these, 67% have computational variant effect predictions. Disease context includes cancer, chronic myelogenous leukemia, BCR-ABL1 positive, and actinic keratosis. Example SRC variants include M1?, G2D, and G2C.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable SRC variants

Examples include M1?, G2D, G2C, G2V, G2G, S3C, S3R, S3T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.